Glasgow Prognostic Score (GPS) and Tumor Response as Biomarkers of Nivolumab Monotherapy in Third- or Later-line Setting for Advanced Gastric Cancer

Conclusion: We present the potential of GPS and DCBC as efficient biomarkers of nivolumab for AGC, that warrants further evaluation.

Source: In Vivo - June 29, 2020 Category: Research Authors: KUROSAKI, T., KAWAKAMI, H., MITANI, S., KAWABATA, R., TAKAHAMA, T., NONAGASE, Y., FUMITA, S., OZAKI, T., CHIBA, Y., TAMURA, T., NAKAGAWA, K. Tags: Clinical Studies Source Type: research